Lite Strategy LITS
NASDAQ LITS
$1.19 +0.03 (+2.59%)
At close: Oct 20, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Times Interest Earned (2011)

Updated

Lite Strategy's Times Interest Earned came in at -20.67 for FY2012 (year ended Jun 30, 2012).

Analysis

Lite Strategy (LITS) Times Interest Earned (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.41
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 10.28
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 7.27
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -42.08
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Lite Strategy 41.82 Mn 9.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -217.44
Sep 30, 2011 -4.87
API Access

Lite Strategy Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=LITS&period=max&api_key=YOUR_API_KEY